Tag Archives: government
Recently, the UK’s Parliament and the Internet conference brought together leading figures from Government, Parliament, academia and the industry to discuss and debate the most pressing policy issues facing the Internet.
As expected, data privacy and security was top of the agenda for much of the day, with a number of discussions highlighting the extent to which consumer data is being exposed to security risks and the need for the right legislation and protection to keep it safe. (more…)
“The public deserves competent, efficient, and responsive service from the Federal Government. Executive departments and agencies must continuously evaluate their performance in meeting this standard and work to improve it.” whitehouse.gov (Executive Order 13571, 1993)
For government organizations striving to improve customer service, the path to success has not always been easy. Incremental improvement initiatives have only provided a marginal return. As previously discussed, these initiatives have fallen drastically short of the win-win scenario threshold. Further, demand for new, better, and faster services is out pacing the ability of these already strapped organizations to deliver on additional capabilities. Budget cuts, new regulations, high staff retirement rates, and a plethora of competing priorities seem to derail the best intentions. (more…)
I. The Problem
At a time when governments at all levels are being called upon to once again, “do more with less,” Data Center Consolidation (DCC) has become a hot topic. While the Federal government has called for a reduction of 2,400 Data Centers down to about 1,200 by 2015, what does that mean, and most important, how does government get there? (more…)
There has been much discussion, particularly in the UK, about banks restricting the use of their investment and retail arms. The thinking process behind this is that investment banking is much riskier and so by drawing a clear line between the two, consumers will be better protected if another financial crisis should hit. (more…)
I recently returned from China and Hong Kong after having met with several CIOs, media and analysts, as well as delivering keynotes focused on customer centricity. When I return to the US after traveling, I’m often asked about the state of IT in the geography I was just in. I’ve been to both China and Hong Kong several times over the past few years, and from my perspective, IT is maturing at a very rapid pace in that region.
During prior trips to Asia, it felt like the old days of data processing. I would speak with senior IT leaders and they were more concerned with the “blocking and tackling” of IT, and not looking at how IT can provide a strategic competitive advantage. Specifically in China, IT leadership was comfortable scaling by applying people to the problem rather than using commercial software. (more…)
A few months ago we blogged about how so many state-level governments are adopting legislation limiting or mandating disclosure of payments to physicians. This spend compliance is now top of mind for many pharmaceutical and medical device companies.
With their physician data spread across the enterprise among accounts payable, expense reporting, ERP, and CTMS systems, it is no wonder that many companies are struggling to conform to the ever stricter reporting requirements differing from state to state.
Not surprisingly, many are turning to Master Data Management as a way of gaining a unified view of physician data across these disparate sources. Many are also discovering that multidomain MDM solutions not only improve compliance but lead to increased sales. Through a single MDM hub they are now able to manage and track critical product master data elements, such as drugs, devices in addition to physician data, and the added quality, accuracy and relationships they uncover has allowed them to optimize and improve their business processes and resulting sales.
This intriguing topic certainly deserves more attention than our simple blog post. Which is why we are delighted to say that on September 24th, there will be a webinar panel moderated by William Looney of Pharmaceutical Executive magazine. Featured panelists will include:
• Hussain A. Mooraj, Vice President, Healthcare & Life Sciences, AMR Research, Inc.
• Anurag Wadehra, Sr. Vice President of Marketing & Product Management, Siperian
• Dan Goldsmith, Partner, IBM GBS
• David J. Eiben, Director, Business IS Consulting – PM Compliance, Boehringer Ingelheim Pharmaceuticals, Inc.
The event is free and anyone can register at www.Pharmexec.com/valuable.
Today Informatica completed the acquisition of Agent Logic.
Whenever a company acquires another, the first question is why. I wanted to give my personal perspective on why this deal is a good one for the industry and our customers. In addition to my comments below, you can read the press release: Informatica Acquires Agent Logic for more information. (more…)
With so many state-level governments adopting legislation limiting or mandating disclosure of payments to physicians, spend compliance is now top of mind for many pharmaceutical companies. Keeping pace with the varied and often conflicting requirements across states has always been difficult. But as momentum for wide-ranging healthcare reform increases, so has talk among stakeholders in Washington and around the industry heated up around creating standards for complying with and enforcing these types of requirements.
Predictably, the idea of national standards for physician spend regulation has both supporters and detractors. Supporters point to the effort required to stay abreast of ever-changing and varied regulation, and the IT cost to support reporting requirements. Detractors decry national regulation as a political power grab rather than a tool for effective social policy, and complain that the general public does not understand the cost of general research and development or the limited profit windows posed by short patent life.
These arguments came to a head last month as Massachusetts introduced the broadest physician-spend law yet. What’s new and different about the Commonwealth’s law? For starters, it’s the first legislation in the U.S. applying to medical device manufacturers as well as pharmaceutical companies. Secondly, the law seems to have teeth that have been missing in the laws of other states, providing for a $5,000 per-incident fine. Previously, the largest public settlement on record was only $10,000 total.
Given the degree of uncertainty about the future of physician-spend legislation, the only certain course of action is to build a reliable, integrated source of physician data that can easily cross-reference to various AP, expense reporting, ERP, and CTMS systems. While reporting requirements will continue to morph, putting in place a reliable data foundation will allow you to rapidly respond to these changes as they occur. There are certain ground rules to follow, however. A strong data foundation must plug equally well into your BI environment, where the bulk of regulatory reporting ill likely occur, as it does into the operational systems that you use to alert personnel to spend limits.
How to go about creating such a strong data foundation? It might not be quite as difficult as it sounds. Read on to discover how one pharma company is using master data management to get a handle on their physician spend management.